When safety discussions for maternal and infant hygiene products shift from 'whether there is a problem' to 'how to detect problems early,' the industry's competitive logic is being rewritten. At a closed-door seminar held in Changxing, Huzhou, Zhejiang in early September, experts from pharmaceuticals, food, medical devices, cosmetics, and hygiene product companies reached a core judgment: compliance is only the baseline, not the endpoint. This cross-industry standards benchmarking signals that safety management is moving from 'firefighting after the fact' to 'prevention at the source.'
Risk Mapping: Reconstructing Safety Boundaries in Three Dimensions
The most critical outcome of the seminar was the proposal to place physical, chemical, and biological risks on the same map. Previously, companies often addressed foreign object complaints, banned substance detection, and microbial exceedances separately, lacking a systematic perspective. Experts suggested establishing a three-dimensional traceability matrix of 'risk type × product scenario × global regulations,' pushing safety standards upstream to raw materials and R&D. This means that in the future, purchasers must not only look at finished product test reports when selecting suppliers but also examine their risk identification capabilities and coverage of global regulatory databases.
Physical foreign object control was distilled into five defense lines: source prevention, process leak prevention, online detection, reliable rejection, and trend warning. This is not a simple list but emphasizes a closed loop. For example, the configuration of metal detectors and X-ray machines is no longer a question of 'whether they exist' but 'whether precision is verified, rejection is reliable, and data is used for trend analysis.' For factories, this means that equipment investment evaluation must shift from single-point efficiency to full-process prevention capability.
Chemical risks were broken down into three sources: indirect raw material suppliers, direct raw material suppliers, and product manufacturers. Experts reminded that many banned substances are not actively added but introduced through auxiliary materials, packaging, or cross-contamination. Companies need to expand from 'targeted detection' to 'non-targeted screening' and continuously accumulate supplier information. This judgment is especially important for small and medium-sized factories, which often lack testing capabilities and rely on upstream commitments; once upstream fails, the entire supply chain bears the pressure.
Biological risk control has a longer chain, covering R&D design, suppliers, water systems, production environments, packaging and storage, and even consumer use. The six defense lines and six-step abnormal event handling method proposed by experts essentially introduce pharmaceutical-grade sterility assurance logic into hygiene product production. For companies involved in wet wipes, diapers, and other skin-contact products, this means that microbial monitoring frequency and early warning values in production environments need to be recalibrated.
Public Opinion and Physical Risks: The Necessity of Integrated Governance
Another noteworthy perspective from the seminar is the integrated governance of public opinion risk and quality risk. Experts pointed out that product compliance does not equal public opinion safety; risks do not stop at the factory gate, and perceptibility determines explosive power. In the age of social media, a foreign object complaint or odor feedback can be amplified within hours. Companies that only focus on test data while ignoring consumer perception often find themselves on the defensive.
This viewpoint has direct implications for brands and foreign trade enterprises: establishing a public opinion monitoring mechanism is no longer an 'extra task' for PR departments but a component of the quality system. When consumers post suspected quality issue images on e-commerce platforms, companies need to quickly trace which batch, which production line, and which raw material link the issue originated from. This requires a sufficiently transparent internal data chain, from raw material batch numbers to production records to logistics information, all of which can be quickly retrieved.